Hillhouse Investment

Total investments

34

Average round size

113M

Portfolio companies

30

Rounds per year

1.79

Lead investments

8

Follow on index

0.12

Exits

5

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareManufacturingMedicalPharmaceuticalTherapeuticsEnergyBiopharma

Investments analytics

Analytics

Total investments
34
Lead investments
8
Exits
5
Rounds per year
1.79
Follow on index
0.12
Investments by industry
  • Biotechnology (11)
  • Health Care (9)
  • Medical (5)
  • Manufacturing (4)
  • Biopharma (3)
  • Show 47 more
Investments by region
  • China (26)
  • South Korea (2)
  • United States (4)
  • Singapore (1)
  • Philippines (1)
Peak activity year
2021
Number of Unicorns
2
Number of Decacorns
2
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
164M
Group Appearance index
0.94
Avg. company exit year
3
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
One Stop Warehouse 19 Jun 2022 Renewable Energy Early Stage Venture 37M Australia, Isabela, Philippines
Silicon Box 09 Jan 2024 Manufacturing, Semiconductor, Electronics Early Stage Venture 200M Central Region, Singapore, Singapore
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.